| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 45,283 | 44,934 | 43,871 | 58,063 | | Cost of Revenue | 41,516 | 40,192 | 38,211 | 51,787 | | | Gross Profit | 3,767 | 4,742 | 5,660 | 6,276 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,813 | 7,601 | 7,653 | 8,942 | | Non Recurring | 17,527 | 13 | (4,252) | 15,598 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (15,930) | (2,872) | 2,259 | (18,264) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,983 | 1,208 | 191 | (5,917) | | Earnings Before Interest And Taxes | (15,188) | (1,664) | 2,450 | (24,181) | | Interest Expense |
-
|
-
|
-
| 2 | | Income Before Tax | (15,188) | (1,664) | 2,450 | (24,183) | | Income Tax Expense | (4,436) | (392) | 1,634 | (3,330) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,752) | (1,272) | 816 | (20,853) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,752) | (1,272) | 816 | (20,853) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,752) | ($1,272) | $816 | ($20,853) |
|
0.51% Nasdaq 
Income Statement
